- CA$36.11m
- CA$34.16m
- $15.10m
- 44
- 36
- 64
- 46
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.107 | 4.52 | 7.15 | 12.5 | 15.1 |
Cost of Revenue | |||||
Gross Profit | 0.107 | 1.74 | 3.35 | 5.33 | 5.12 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.83 | 20.1 | 7.13 | 12.4 | 16.5 |
Operating Profit | -2.73 | -15.5 | 0.015 | 0.036 | -1.38 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.68 | -15.5 | 0.049 | 0.026 | -1.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.59 | -14.7 | 0.104 | -0.19 | -1.35 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.59 | -14.7 | 0.104 | -0.19 | -1.35 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.59 | -14.7 | 0.104 | -0.19 | -1.35 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.036 | -0.045 | 0.001 | -0.001 | -0.01 |